Ripretinib abre un nuevo capítulo en el tratamiento del GIST...

hat ein neuen Blog hinzugefügt Health

2026-01-09 07:28:40 -

Ripretinib abre un nuevo capítulo en el tratamiento del GIST avanzado

In the field of targeted therapies for malignant tumors, the advent of ripretinib (QINLOCK) has brought renewed hope to patients with gastrointestinal stromal tumors (GIST). In particular, it provides a critical treatment option for patients whose disease continues to progress after multiple lines of therapy. As a broad-spectrum kinase inhibitor with a novel and innovative mechanism of...

0 Kommentare 0 Geteilt 127 Ansichten 0 Bewertungen